APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Animal Softgel Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-Animal Softgel Capsules Industry Growth and Trends Forecast to 2032

28 December 2025108 pages

Choose your research edition.

Industry ResearchNon-Animal Softgel Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Animal Softgel Capsules Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Non-Animal Softgel Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Animal Softgel Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Animal Softgel Capsules Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non-Animal Softgel Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Animal Softgel Capsules include Sirio, Erkang, Baihe, Aland, Sunsho Pharmaceutical, Robinson Pharma, Procaps Laboratorios, Fuji Capsule and EuroCaps, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-Animal Softgel Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-Animal Softgel Capsules market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-Animal Softgel Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-Animal Softgel Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-Animal Softgel Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-Animal Softgel Capsules Market by Company

Sirio

Erkang

Baihe

Aland

Sunsho Pharmaceutical

Robinson Pharma

Procaps Laboratorios

Fuji Capsule

EuroCaps

Catalent

Captek

Bahrain Pharma

Aenova

Non-Animal Softgel Capsules Segment by Type

Starch Softgel

Gellan Gum Softgel

Carrageenan Softgel

Non-Animal Softgel Capsules Segment by Application

Health Supplements

Pharmaceutical

Others

Non-Animal Softgel Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Animal Softgel Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Animal Softgel Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Animal Softgel Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-Animal Softgel Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Starch Softgel Table 2. Major Company of Gellan Gum Softgel Table 3. Major Company of Carrageenan Softgel Table 4. Global Non-Animal Softgel Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 6. Global Non-Animal Softgel Capsules Sales Market Share in Volume by Type (2021-2026) Table 7. Global Non-Animal Softgel Capsules Sales by Type (2021-2026) & (US$ Million) Table 8. Global Non-Animal Softgel Capsules Sales Market Share in Value by Type (2021-2026) Table 9. Global Non-Animal Softgel Capsules Price by Type (2021-2026) & (US$/Unit) Table 10. Global Non-Animal Softgel Capsules Sales by Type (2027-2032) & (M Units) Table 11. Global Non-Animal Softgel Capsules Sales Market Share in Volume by Type (2027-2032) Table 12. Global Non-Animal Softgel Capsules Sales by Type (2027-2032) & (US$ Million) Table 13. Global Non-Animal Softgel Capsules Sales Market Share in Value by Type (2027-2032) Table 14. Global Non-Animal Softgel Capsules Price by Type (2027-2032) & (US$/Unit) Table 15. North America Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 16. North America Non-Animal Softgel Capsules Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 18. Europe Non-Animal Softgel Capsules Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Non-Animal Softgel Capsules Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 22. Latin America Non-Animal Softgel Capsules Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Non-Animal Softgel Capsules Sales by Type (2021-2026) & (US$ Million) Table 25. Non-Animal Softgel Capsules Industry Trends Table 26. Non-Animal Softgel Capsules Industry Drivers Table 27. Non-Animal Softgel Capsules Industry Opportunities and Challenges Table 28. Non-Animal Softgel Capsules Industry Restraints Table 29. Global Non-Animal Softgel Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Non-Animal Softgel Capsules Revenue Market Share by Company (2021-2026) Table 31. Global Non-Animal Softgel Capsules Sales by Company (2021-2026) & (M Units) Table 32. Global Non-Animal Softgel Capsules Sales Share by Company (2021-2026) Table 33. Global Non-Animal Softgel Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Non-Animal Softgel Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Non-Animal Softgel Capsules Major Company Production Sites and Headquarters Table 36. Global Non-Animal Softgel Capsules Company, Product Type & Application Table 37. Global Non-Animal Softgel Capsules Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Non-Animal Softgel Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Non-Animal Softgel Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Non-Animal Softgel Capsules Sales by Region (2021-2026) & (M Units) Table 42. Global Non-Animal Softgel Capsules Sales Market Share in Volume by Region (2021-2026) Table 43. Global Non-Animal Softgel Capsules Sales by Region (2021-2026) & (US$ Million) Table 44. Global Non-Animal Softgel Capsules Sales Market Share in Value by Region (2021-2026) Table 45. Global Non-Animal Softgel Capsules Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Non-Animal Softgel Capsules Sales by Region (2027-2032) & (M Units) Table 47. Global Non-Animal Softgel Capsules Sales Market Share in Volume by Region (2027-2032) Table 48. Global Non-Animal Softgel Capsules Sales by Region (2027-2032) & (US$ Million) Table 49. Global Non-Animal Softgel Capsules Sales Market Share in Value by Region (2027-2032) Table 50. Global Non-Animal Softgel Capsules Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Non-Animal Softgel Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 53. Global Non-Animal Softgel Capsules Sales Market Share in Volume by Application (2021-2026) Table 54. Global Non-Animal Softgel Capsules Sales by Application (2021-2026) & (US$ Million) Table 55. Global Non-Animal Softgel Capsules Sales Market Share in Value by Application (2021-2026) Table 56. Global Non-Animal Softgel Capsules Price by Application (2021-2026) & (US$/Unit) Table 57. Global Non-Animal Softgel Capsules Sales by Application (2027-2032) & (M Units) Table 58. Global Non-Animal Softgel Capsules Sales Market Share in Volume by Application (2027-2032) Table 59. Global Non-Animal Softgel Capsules Sales by Application (2027-2032) & (US$ Million) Table 60. Global Non-Animal Softgel Capsules Sales Market Share in Value by Application (2027-2032) Table 61. Global Non-Animal Softgel Capsules Price by Application (2027-2032) & (US$/Unit) Table 62. North America Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 63. North America Non-Animal Softgel Capsules Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 65. Europe Non-Animal Softgel Capsules Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Non-Animal Softgel Capsules Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 69. Latin America Non-Animal Softgel Capsules Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Non-Animal Softgel Capsules Sales by Application (2021-2026) & (US$ Million) Table 72. Sirio Company Information Table 73. Sirio Business Overview Table 74. Sirio Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sirio Non-Animal Softgel Capsules Product Portfolio Table 76. Sirio Recent Development Table 77. Erkang Company Information Table 78. Erkang Business Overview Table 79. Erkang Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Erkang Non-Animal Softgel Capsules Product Portfolio Table 81. Erkang Recent Development Table 82. Baihe Company Information Table 83. Baihe Business Overview Table 84. Baihe Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Baihe Non-Animal Softgel Capsules Product Portfolio Table 86. Baihe Recent Development Table 87. Aland Company Information Table 88. Aland Business Overview Table 89. Aland Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Aland Non-Animal Softgel Capsules Product Portfolio Table 91. Aland Recent Development Table 92. Sunsho Pharmaceutical Company Information Table 93. Sunsho Pharmaceutical Business Overview Table 94. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio Table 96. Sunsho Pharmaceutical Recent Development Table 97. Robinson Pharma Company Information Table 98. Robinson Pharma Business Overview Table 99. Robinson Pharma Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Robinson Pharma Non-Animal Softgel Capsules Product Portfolio Table 101. Robinson Pharma Recent Development Table 102. Procaps Laboratorios Company Information Table 103. Procaps Laboratorios Business Overview Table 104. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio Table 106. Procaps Laboratorios Recent Development Table 107. Fuji Capsule Company Information Table 108. Fuji Capsule Business Overview Table 109. Fuji Capsule Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Fuji Capsule Non-Animal Softgel Capsules Product Portfolio Table 111. Fuji Capsule Recent Development Table 112. EuroCaps Company Information Table 113. EuroCaps Business Overview Table 114. EuroCaps Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. EuroCaps Non-Animal Softgel Capsules Product Portfolio Table 116. EuroCaps Recent Development Table 117. Catalent Company Information Table 118. Catalent Business Overview Table 119. Catalent Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Catalent Non-Animal Softgel Capsules Product Portfolio Table 121. Catalent Recent Development Table 122. Captek Company Information Table 123. Captek Business Overview Table 124. Captek Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Captek Non-Animal Softgel Capsules Product Portfolio Table 126. Captek Recent Development Table 127. Bahrain Pharma Company Information Table 128. Bahrain Pharma Business Overview Table 129. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio Table 131. Bahrain Pharma Recent Development Table 132. Aenova Company Information Table 133. Aenova Business Overview Table 134. Aenova Non-Animal Softgel Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Aenova Non-Animal Softgel Capsules Product Portfolio Table 136. Aenova Recent Development Table 137. North America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 138. North America Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 139. North America Non-Animal Softgel Capsules Sales Market Share by Country (2021-2026) Table 140. North America Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032) & (M Units) Table 141. North America Non-Animal Softgel Capsules Sales Market Share Forecast by Country (2027-2032) Table 142. North America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Non-Animal Softgel Capsules Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Non-Animal Softgel Capsules Market Share by Country (2021-2026) Table 145. North America Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Non-Animal Softgel Capsules Market Share Forecast by Country (2027-2032) Table 147. Europe Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 148. Europe Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 149. Europe Non-Animal Softgel Capsules Sales Market Share by Country (2021-2026) Table 150. Europe Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032) & (M Units) Table 151. Europe Non-Animal Softgel Capsules Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Non-Animal Softgel Capsules Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Non-Animal Softgel Capsules Market Share by Country (2021-2026) Table 155. Europe Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Non-Animal Softgel Capsules Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 159. Asia-Pacific Non-Animal Softgel Capsules Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032) & (M Units) Table 161. Asia-Pacific Non-Animal Softgel Capsules Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Non-Animal Softgel Capsules Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Non-Animal Softgel Capsules Market Share by Country (2021-2026) Table 165. Asia-Pacific Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Non-Animal Softgel Capsules Market Share Forecast by Country (2027-2032) Table 167. Latin America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 168. Latin America Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 169. Latin America Non-Animal Softgel Capsules Sales Market Share by Country (2021-2026) Table 170. Latin America Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032) & (M Units) Table 171. Latin America Non-Animal Softgel Capsules Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Non-Animal Softgel Capsules Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Non-Animal Softgel Capsules Market Share by Country (2021-2026) Table 175. Latin America Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Non-Animal Softgel Capsules Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 179. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032) & (M Units) Table 181. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Non-Animal Softgel Capsules Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Non-Animal Softgel Capsules Market Share by Country (2021-2026) Table 185. Middle East and Africa Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Non-Animal Softgel Capsules Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Non-Animal Softgel Capsules Distributors List Table 190. Non-Animal Softgel Capsules Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Non-Animal Softgel Capsules Image Figure 2. Global Non-Animal Softgel Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Animal Softgel Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Animal Softgel Capsules Sales (2021-2032) & (M Units) Figure 5. Starch Softgel Image Figure 6. Global Starch Softgel Sales YoY Growth (2021-2032) & (M Units) Figure 7. Gellan Gum Softgel Image Figure 8. Global Gellan Gum Softgel Sales YoY Growth (2021-2032) & (M Units) Figure 9. Carrageenan Softgel Image Figure 10. Global Carrageenan Softgel Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Non-Animal Softgel Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Non-Animal Softgel Capsules Market Share by Type 2025 VS 2032 Figure 13. North America Non-Animal Softgel Capsules Sales Market Share in Volume by Type in 2025 Figure 14. North America Non-Animal Softgel Capsules Sales Market Share in Value by Type in 2025 Figure 15. Europe Non-Animal Softgel Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Europe Non-Animal Softgel Capsules Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Non-Animal Softgel Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Non-Animal Softgel Capsules Sales Market Share in Value by Type in 2025 Figure 19. Latin America Non-Animal Softgel Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Non-Animal Softgel Capsules Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Non-Animal Softgel Capsules Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Health Supplements Image Figure 26. Global Health Supplements Sales YoY Growth (2021-2032) & (M Units) Figure 27. Pharmaceutical Image Figure 28. Global Pharmaceutical Sales YoY Growth (2021-2032) & (M Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 31. Global Non-Animal Softgel Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Non-Animal Softgel Capsules Market Share by Application 2025 VS 2032 Figure 33. North America Non-Animal Softgel Capsules Sales Market Share in Volume by Application in 2025 Figure 34. North America Non-Animal Softgel Capsules Sales Market Share in Value by Application in 2025 Figure 35. Europe Non-Animal Softgel Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Europe Non-Animal Softgel Capsules Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Non-Animal Softgel Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Non-Animal Softgel Capsules Sales Market Share in Value by Application in 2025 Figure 39. Latin America Non-Animal Softgel Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Non-Animal Softgel Capsules Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share in Value by Application in 2025 Figure 43. North America Non-Animal Softgel Capsules Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 44. North America Non-Animal Softgel Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Non-Animal Softgel Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non-Animal Softgel Capsules Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. Europe Non-Animal Softgel Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Non-Animal Softgel Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non-Animal Softgel Capsules Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Asia-Pacific Non-Animal Softgel Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Non-Animal Softgel Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non-Animal Softgel Capsules Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Latin America Non-Animal Softgel Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Non-Animal Softgel Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non-Animal Softgel Capsules Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Middle East and Africa Non-Animal Softgel Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Non-Animal Softgel Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Non-Animal Softgel Capsules Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Non-Animal Softgel Capsules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Starch Softgel
  • Gellan Gum Softgel
  • Carrageenan Softgel
Applications
  • Health Supplements
  • Pharmaceutical
  • Others
Companies covered
  • Sirio
  • Erkang
  • Baihe
  • Aland
  • Sunsho Pharmaceutical
  • Robinson Pharma
  • Procaps Laboratorios
  • Fuji Capsule
  • EuroCaps
  • Catalent
  • Captek
  • Bahrain Pharma
  • Aenova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-Animal Softgel Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-Animal Softgel Capsules Market by Type
  6. 1.3.1 Starch Softgel
  7. 1.3.2 Gellan Gum Softgel
  8. 1.3.3 Carrageenan Softgel
  9. 1.4 Global Non-Animal Softgel Capsules Market Size by Type
  10. 1.4.1 Global Non-Animal Softgel Capsules Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Non-Animal Softgel Capsules Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Non-Animal Softgel Capsules Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Non-Animal Softgel Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Non-Animal Softgel Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Non-Animal Softgel Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Non-Animal Softgel Capsules Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Non-Animal Softgel Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-Animal Softgel Capsules Industry Trends
  2. 2.2 Non-Animal Softgel Capsules Industry Drivers
  3. 2.3 Non-Animal Softgel Capsules Industry Opportunities and Challenges
  4. 2.4 Non-Animal Softgel Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-Animal Softgel Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-Animal Softgel Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Non-Animal Softgel Capsules Price (2021-2026)
  4. 3.4 Global Non-Animal Softgel Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Animal Softgel Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Non-Animal Softgel Capsules Company, Product Type & Application
  7. 3.7 Global Non-Animal Softgel Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Animal Softgel Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Animal Softgel Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Animal Softgel Capsules Tier 1, Tier 2, and Tier 3
4 Non-Animal Softgel Capsules Regional Status and Outlook
  1. 4.1 Global Non-Animal Softgel Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-Animal Softgel Capsules Historic Market Size by Region
  3. 4.2.1 Global Non-Animal Softgel Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-Animal Softgel Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-Animal Softgel Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-Animal Softgel Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Non-Animal Softgel Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-Animal Softgel Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-Animal Softgel Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-Animal Softgel Capsules by Application
  1. 5.1 Non-Animal Softgel Capsules Market by Application
  2. 5.1.1 Health Supplements
  3. 5.1.2 Pharmaceutical
  4. 5.1.3 Others
  5. 5.2 Global Non-Animal Softgel Capsules Market Size by Application
  6. 5.2.1 Global Non-Animal Softgel Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Non-Animal Softgel Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Non-Animal Softgel Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Non-Animal Softgel Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Non-Animal Softgel Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Non-Animal Softgel Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Non-Animal Softgel Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Non-Animal Softgel Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sirio
  2. 6.1.1 Sirio Company Information
  3. 6.1.2 Sirio Business Overview
  4. 6.1.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sirio Non-Animal Softgel Capsules Product Portfolio
  6. 6.1.5 Sirio Recent Developments
  7. 6.2 Erkang
  8. 6.2.1 Erkang Company Information
  9. 6.2.2 Erkang Business Overview
  10. 6.2.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Erkang Non-Animal Softgel Capsules Product Portfolio
  12. 6.2.5 Erkang Recent Developments
  13. 6.3 Baihe
  14. 6.3.1 Baihe Company Information
  15. 6.3.2 Baihe Business Overview
  16. 6.3.3 Baihe Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baihe Non-Animal Softgel Capsules Product Portfolio
  18. 6.3.5 Baihe Recent Developments
  19. 6.4 Aland
  20. 6.4.1 Aland Company Information
  21. 6.4.2 Aland Business Overview
  22. 6.4.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Aland Non-Animal Softgel Capsules Product Portfolio
  24. 6.4.5 Aland Recent Developments
  25. 6.5 Sunsho Pharmaceutical
  26. 6.5.1 Sunsho Pharmaceutical Company Information
  27. 6.5.2 Sunsho Pharmaceutical Business Overview
  28. 6.5.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
  30. 6.5.5 Sunsho Pharmaceutical Recent Developments
  31. 6.6 Robinson Pharma
  32. 6.6.1 Robinson Pharma Company Information
  33. 6.6.2 Robinson Pharma Business Overview
  34. 6.6.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
  36. 6.6.5 Robinson Pharma Recent Developments
  37. 6.7 Procaps Laboratorios
  38. 6.7.1 Procaps Laboratorios Company Information
  39. 6.7.2 Procaps Laboratorios Business Overview
  40. 6.7.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
  42. 6.7.5 Procaps Laboratorios Recent Developments
  43. 6.8 Fuji Capsule
  44. 6.8.1 Fuji Capsule Company Information
  45. 6.8.2 Fuji Capsule Business Overview
  46. 6.8.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
  48. 6.8.5 Fuji Capsule Recent Developments
  49. 6.9 EuroCaps
  50. 6.9.1 EuroCaps Company Information
  51. 6.9.2 EuroCaps Business Overview
  52. 6.9.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
  54. 6.9.5 EuroCaps Recent Developments
  55. 6.10 Catalent
  56. 6.10.1 Catalent Company Information
  57. 6.10.2 Catalent Business Overview
  58. 6.10.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Catalent Non-Animal Softgel Capsules Product Portfolio
  60. 6.10.5 Catalent Recent Developments
  61. 6.11 Captek
  62. 6.11.1 Captek Company Information
  63. 6.11.2 Captek Business Overview
  64. 6.11.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Captek Non-Animal Softgel Capsules Product Portfolio
  66. 6.11.5 Captek Recent Developments
  67. 6.12 Bahrain Pharma
  68. 6.12.1 Bahrain Pharma Company Information
  69. 6.12.2 Bahrain Pharma Business Overview
  70. 6.12.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
  72. 6.12.5 Bahrain Pharma Recent Developments
  73. 6.13 Aenova
  74. 6.13.1 Aenova Company Information
  75. 6.13.2 Aenova Business Overview
  76. 6.13.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Aenova Non-Animal Softgel Capsules Product Portfolio
  78. 6.13.5 Aenova Recent Developments
7 North America by Country
  1. 7.1 North America Non-Animal Softgel Capsules Sales by Country
  2. 7.1.1 North America Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-Animal Softgel Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-Animal Softgel Capsules Market Size by Country
  6. 7.2.1 North America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-Animal Softgel Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-Animal Softgel Capsules Sales by Country
  2. 8.1.1 Europe Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-Animal Softgel Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-Animal Softgel Capsules Market Size by Country
  6. 8.2.1 Europe Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-Animal Softgel Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-Animal Softgel Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-Animal Softgel Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-Animal Softgel Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-Animal Softgel Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-Animal Softgel Capsules Sales by Country
  2. 10.1.1 South America Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-Animal Softgel Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-Animal Softgel Capsules Market Size by Country
  6. 10.2.1 South America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-Animal Softgel Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-Animal Softgel Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-Animal Softgel Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-Animal Softgel Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-Animal Softgel Capsules Value Chain Analysis
  2. 12.1.1 Non-Animal Softgel Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-Animal Softgel Capsules Production Mode & Process
  7. 12.2 Non-Animal Softgel Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-Animal Softgel Capsules Distributors
  10. 12.2.3 Non-Animal Softgel Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst